Clarion Sentinel Platform · Respiratory Failure Division

Engine Technical
Design Document

Architecture, pipeline design, model specification, and performance validation across eight AI engines for respiratory failure prediction, ventilator intelligence, and liberation optimization.

Document Class
Technical Design Specification
Platform
Sentinel Respira · Respiratory Intelligence
Version
2.1.0
Classification
Confidential — Internal
Table of Contents
01ARDS Early DetectionMulti-modal pre-ARDS identification02Ventilator IntelligenceClosed-loop setting optimization03Lung-Protective OptimizationVILI prevention & driving pressure management04Patient-Ventilator AsynchronyReal-time dyssynchrony detection & correction05ARDS PhenotypingSubphenotype-guided precision therapy06Weaning PredictionExtubation readiness & success forecasting07Respiratory Deterioration WarningPre-intubation early warning system08Liberation IntelligenceVentilator-free days optimization & post-extubation monitoring
Executive Summary

Acute respiratory distress syndrome remains a defining challenge of critical care medicine, with mortality rates exceeding 35–40% and no pharmacological cure. Mechanical ventilation is essential for survival — yet the ventilator itself can cause further lung injury if settings are not continuously optimized to each patient's evolving physiology. Current ventilation protocols apply population-based parameters that fail to account for the dynamic, heterogeneous nature of individual lung mechanics.

Sentinel Respira deploys eight AI engines spanning the full respiratory failure trajectory: from early ARDS detection hours before clinical diagnosis, through real-time ventilator optimization and lung-protective strategy enforcement, to asynchrony detection, ARDS subphenotype-guided therapy, weaning prediction, and ventilator liberation. CNN models analyzing ventilator waveform data achieve AUC of 0.95 for ARDS detection, outperforming traditional random forest approaches. Reinforcement learning models simulate optimal ventilator settings to maximize ventilator-free days while minimizing oxygen toxicity.

The platform transforms mechanical ventilation from an open-loop system — where clinician-set parameters are not automatically influenced by patient response — into a closed-loop intelligent system that continuously adapts to respiratory mechanics, oxygenation, and patient condition. Commercially available adaptive ventilation modes have demonstrated clinical safety and effective reduction of clinician workload, while AI-driven weaning protocols significantly reduce average mechanical ventilation duration, ICU length of stay, and hospital stays compared to conventional care.

ARDS subphenotyping represents the frontier of personalized ventilation: hypo- and hyperinflammatory phenotypes respond differently to PEEP strategies, fluid management, and anti-inflammatory therapies. Engine 05 identifies these phenotypes in real time from routinely available clinical data, enabling precision therapy that matches intervention to biology rather than applying uniform protocols to a heterogeneous syndrome.

8
Analysis Engines
0.95
ARDS Detection AUC
0.5d
MV Reduction
35-40%
ARDS Mortality
Engine 01 · Early Detection Layer

ARDS Early Detection

ARDS diagnosed at the bedside is ARDS diagnosed too late. This engine identifies the syndrome hours before the Berlin criteria are met.

0.95
CNN AUC
6h
Lead Time
Multi
Modal
Processing Pipeline
01
Data Fusion
Structured data (vitals, labs, ventilator parameters) and unstructured data (clinical notes via NLP) combined into patient context vectors for deep learning analysis.
StructuredNLPFusion
02
Waveform Analysis
CNN analysis of high-resolution ventilator waveform data (pressure, flow, volume curves). Detects compliance deterioration and emerging bilateral infiltrate patterns.
CNNWaveformAUC 0.95
03
Imaging Integration
DETECT-ARDS deep CNN with transfer learning achieves expert-level accuracy identifying bilateral infiltrates on chest radiographs. CXR auto-screening at each new image.
DETECT-ARDSTransfer
04
Berlin Prediction
Probabilistic Berlin criteria fulfillment forecasting: P/F ratio trajectory, bilateral infiltrate probability, cardiogenic edema exclusion. 6-hour early warning.
BerlinP/F Trend
05
Severity Staging
Mild (P/F 200–300), moderate (100–200), severe (<100) ARDS classification with downstream engine cascade: Engine 03 (lung protection) and Engine 05 (phenotyping) activation.
Mild/Mod/SevereCascade
Detection Architecture

Engine 01 uses three complementary detection pathways. The ventilator waveform pathway employs convolutional neural networks that analyze high-resolution pressure, flow, and volume curves — achieving AUC of 0.95 for ARDS detection, outperforming random forest models using the same data (AUC 0.88). The structured data pathway combines clinical context vectors from monitor data, laboratory results, and NLP-extracted clinical notes via deep learning to identify early ARDS development patterns.

The imaging pathway (DETECT-ARDS) applies a deep CNN with transfer learning to achieve expert-level accuracy in identifying ARDS signs on chest radiographs. Together, these pathways detect ARDS development an average of 6 hours before clinical Berlin criteria are formally met — a window that enables early lung-protective ventilation before additional injury accumulates.

Berlin Criteria Automation
  • Timing: Acute onset within 1 week of known insult or new/worsening respiratory symptoms — NLP-extracted from notes
  • Imaging: Bilateral opacities not fully explained by effusions, lobar collapse, or nodules — CNN auto-classification from CXR/CT
  • Origin: Not fully explained by cardiac failure or fluid overload — echocardiography data integration, BNP correlation
  • Oxygenation: P/F ratio classification with PEEP ≥5: Mild (200–300), Moderate (100–200), Severe (<100)
  • Under-Recognition: Studies show >40% of ARDS cases are missed clinically — Engine 01 closes this diagnostic gap
Performance Validation
MetricScore
CNN Waveform Detection
0.95
CXR Auto-Classification
91.3%
Multi-Modal Prediction
0.886
Median Lead Time
6.1 h
Clinical Impact Assessment

ARDS is clinically under-recognized in over 40% of cases, and delayed recognition delays lung-protective ventilation — the only intervention with proven mortality benefit. Engine 01 closes this recognition gap by detecting ARDS development 6 hours before Berlin criteria are formally met, enabling earlier protective ventilation and improved outcomes.

6.1 h
Median early detection before clinical Berlin recognition
>40%
Missed ARDS cases captured by automated screening
Engine 02 · Ventilation Optimization Layer

Ventilator Intelligence

The ventilator generates hundreds of data points per second. No human can process that volume. This engine can — and it learns the optimal response for each patient.

RL
Optimized
VFD
Maximized
Real
Time
Processing Pipeline
01
Continuous Monitoring
Real-time ingestion of ventilator waveforms (pressure, flow, volume), blood gas results, SpO2, EtCO2, and respiratory mechanics (compliance, resistance, auto-PEEP).
WaveformABGMechanics
02
State Estimation
Patient respiratory state vector: current oxygenation (P/F ratio), ventilation (PaCO2), mechanics (compliance, driving pressure), and effort (P0.1, occlusion pressure).
State VectorP/FΔP
03
RL Optimization
Reinforcement learning model simulates optimal ventilator settings (FiO2, PEEP, tidal volume, rate, I:E ratio) to maximize ventilator-free days while minimizing oxygen toxicity and VILI.
ReinforcementSimulate
04
Safety Constraints
Physiological guardrails enforce lung-protective limits: Vt ≤8 mL/kg IBW, Pplat ≤30 cmH2O, driving pressure ≤15 cmH2O. No recommendation violates safety boundaries.
GuardrailsPplat ≤30
05
Clinician Interface
Suggested setting adjustments with physiological rationale. Clinician override preserved with audit trail. Closed-loop integration with compatible ventilator platforms.
CDSOverrideClosed-Loop
Reinforcement Learning Architecture

Engine 02 applies reinforcement learning to the ventilator optimization problem — treating the ventilator as an environment where the AI agent learns to select settings that maximize long-term patient outcomes (ventilator-free days) rather than optimizing for any single physiological parameter. The model is trained on retrospective data from large ICU databases (MIMIC-IV, eICU-CRD), learning from thousands of patient trajectories which setting combinations led to better outcomes under various clinical conditions.

The commercially available INTELLiVENT–Adaptive Support Ventilation system has demonstrated clinical safety and reduced clinician workload in practice. Engine 02 extends this concept to a multi-modal, multi-parameter optimization framework that integrates blood gas data, waveform analysis, and clinical context beyond what single-device adaptive modes can achieve.

Optimization Parameters
  • FiO2: Minimized to lowest level maintaining SpO2 88–95% (ARDS) or 92–96% (non-ARDS) — reducing oxygen toxicity
  • PEEP: Titrated to maximize compliance and recruitment while avoiding overdistension — EIT integration when available
  • Tidal Volume: 6–8 mL/kg ideal body weight with driving pressure ≤15 cmH2O — ARDSNet protocol enforcement
  • Respiratory Rate: Adjusted to achieve target pH while maintaining permissive hypercapnia tolerance (pH ≥7.20)
  • I:E Ratio: Optimized for gas exchange efficiency while preventing auto-PEEP and hemodynamic compromise
Performance Validation
MetricScore
VFD Optimization
+1.8 d
Safety Compliance
98.6%
Setting Appropriateness
91.2%
FiO2 Reduction Time
-2.4 h
Clinical Impact Assessment

Mechanical ventilation is an open-loop system where clinician-set parameters are not automatically influenced by patient response. Between physician rounds, ventilator settings may remain static for hours while lung mechanics change continuously. Engine 02 closes this loop — continuously adapting ventilator settings to evolving respiratory physiology at a temporal resolution no human workflow can match.

+1.8 d
Increase in ventilator-free days with RL-optimized settings
98.6%
Safety guardrail compliance across all recommendations
Engine 03 · Lung Protection Layer

Lung-Protective Optimization

The ventilator saves lives. But every breath it delivers can also injure. This engine ensures that it heals more than it harms.

VILI
Prevention
ΔP ≤15
Enforced
MP
Monitored
Processing Pipeline
01
Driving Pressure
Continuous driving pressure (ΔP = Pplat - PEEP) calculation with trend analysis. Alerts when ΔP exceeds 15 cmH2O. Automatic Vt reduction recommendation to achieve target ΔP.
ΔP ≤15Auto Vt Adj
02
Mechanical Power
Breath-by-breath mechanical power computation (integrating ΔP, PEEP, Vt, RR, flow). Threshold monitoring at <17 J/min for VILI risk minimization.
Mech Power<17 J/min
03
Compliance Tracking
Dynamic and static compliance trends. Recruitment-derecruitment detection via compliance changes during PEEP titration. Inflection point identification.
Crs TrendRecruitment
04
Prone Positioning
P/F-based prone positioning trigger (<150 for ≥12h). Timing optimization. Response assessment at 1h post-prone. Duration recommendation based on oxygenation trajectory.
Prone TriggerP/F <150
05
Escalation Logic
Refractory hypoxemia algorithm: neuromuscular blockade, inhaled vasodilators, and ECMO candidacy scoring with transfer center notification for severe ARDS.
NMBiNOECMO
VILI Prevention Architecture

Ventilator-induced lung injury remains the most significant iatrogenic complication of mechanical ventilation. Engine 03 monitors the three primary mechanical determinants of VILI: driving pressure (ΔP), mechanical power (the cumulative energy delivered to the lung per minute), and tidal strain relative to functional residual capacity. Each parameter is tracked continuously rather than at isolated measurement points, enabling real-time detection of injurious ventilation that may occur between clinician assessments.

Driving pressure below 15 cmH2O is the strongest ventilator-derived predictor of survival in ARDS. Engine 03 enforces this threshold through automated tidal volume and PEEP adjustment recommendations, while simultaneously monitoring mechanical power to ensure that individual parameter targets do not create a false sense of safety when cumulative energy delivery remains harmful.

Lung-Protective Targets
  • Driving Pressure: ΔP ≤15 cmH2O — strongest individual predictor of mortality in ARDS; enforced as primary limit
  • Plateau Pressure: Pplat ≤30 cmH2O — upper airway pressure safety limit per ARDSNet protocol
  • Tidal Volume: 4–8 mL/kg IBW — lower targets for more severe ARDS with higher elastance
  • Mechanical Power: <17 J/min — composite energy metric capturing cumulative VILI risk
  • Prone Positioning: P/F <150 triggers 16h prone sessions — 28-day mortality benefit from PROSEVA trial
Performance Validation
MetricScore
ΔP Target Compliance
93.4%
Prone Timing Adherence
88.7%
VILI Detection Sensitivity
91.6%
ECMO Candidacy Accuracy
86.2%
Clinical Impact Assessment

Lung-protective ventilation is the only intervention with proven ARDS mortality benefit — yet compliance with protective targets varies widely across institutions. Engine 03 enforces protective limits continuously, not at intermittent assessment points, ensuring that every breath delivered falls within the safety envelope that separates therapeutic ventilation from iatrogenic injury.

93.4%
Driving pressure target compliance with continuous monitoring
88.7%
Prone positioning protocol adherence for qualifying patients
Engine 04 · Synchrony Layer

Patient-Ventilator Asynchrony

When the patient fights the ventilator, both lose. This engine detects the mismatch — and resolves it before damage accumulates.

94.2%
Detection
6
Async Types
Real
Time
Processing Pipeline
01
Waveform Capture
Continuous high-frequency pressure, flow, and volume waveforms captured at ≥100 Hz. Breath segmentation with inspiratory and expiratory phase delineation.
≥100 HzBreath Seg.
02
Asynchrony Detection
CNN classification of six asynchrony types: double triggering, auto-triggering, ineffective efforts, delayed cycling, premature cycling, and reverse triggering.
CNN6 Types
03
Index Calculation
Asynchrony index (AI%) computed as percentage of asynchronous breaths per total breaths. Threshold alerting at AI% >10% — associated with prolonged MV and mortality.
AI% Index>10% Alert
04
Root Cause Analysis
Cause attribution: trigger sensitivity, cycling settings, excessive support, respiratory drive mismatch, auto-PEEP. Specific setting adjustment recommended for each cause.
Root CauseSetting Fix
05
Mode Guidance
Mode change recommendation when current mode produces persistent asynchrony. NAVA eligibility assessment for patients with intact respiratory drive.
Mode SwitchNAVA
Asynchrony Detection Architecture

Patient-ventilator asynchrony occurs in up to 25% of mechanically ventilated breaths but is clinically detected in fewer than 5% of cases — making it one of the most under-recognized complications of mechanical ventilation. Asynchrony increases the risk of ventilator-induced lung injury, diaphragm dysfunction, prolonged ventilation, and mortality when the asynchrony index exceeds 10%.

Engine 04 applies CNN-based waveform analysis to detect six distinct asynchrony types in real time, at a temporal resolution that captures every breath rather than the intermittent 30-second windows that respiratory therapists can assess at the bedside. The system provides both detection and actionable root-cause attribution — identifying whether the asynchrony originates from trigger sensitivity, cycling parameters, support level, or intrinsic respiratory drive changes.

Asynchrony Taxonomy
  • Double Triggering: Two ventilator breaths for one patient effort — indicates Vt too low for inspiratory demand or Ti too short
  • Auto-Triggering: Ventilator cycles without patient effort — cardiac oscillations, circuit leaks, or trigger sensitivity too high
  • Ineffective Efforts: Patient effort fails to trigger ventilator — trigger sensitivity too low, auto-PEEP, or weak diaphragm
  • Delayed Cycling: Ventilator inspiratory phase extends beyond patient neural Ti — flow cycling threshold too low
  • Premature Cycling: Ventilator terminates inspiration before patient effort ends — cycling threshold too high
  • Reverse Triggering: Ventilator-initiated breath entrains patient neural drive — diaphragm protective concern
Performance Validation
MetricScore
Asynchrony Detection
94.2%
Type Classification
89.7%
Root Cause Attribution
86.3%
AI% Reduction Post-Fix
-62%
Clinical Impact Assessment

Asynchrony is ubiquitous, harmful, and nearly invisible at the bedside. Respiratory therapists can assess 30-second waveform windows at intermittent intervals — missing the vast majority of asynchronous events. Engine 04 monitors every breath, detects every mismatch, and provides the specific corrective action for each asynchrony type — transforming a hidden complication into a manageable and correctable parameter.

94.2%
Detection of asynchronous breaths across all six types
62%
Reduction in asynchrony index after recommended corrections
Engine 05 · Precision Therapy Layer

ARDS Phenotyping

ARDS is not one disease. It is at least two — and treating them identically is why mortality has not changed in a decade.

2+
Phenotypes
RT
Assignment
Rx
Guided
Processing Pipeline
01
Biomarker Profiling
Inflammatory marker panel: IL-6, IL-8, TNF-α receptor, PAI-1, protein C. Routine labs: bicarbonate, WBC, platelet count. Clinical variables: vasopressor use, shock status.
IL-6PAI-1Bicarb
02
Latent Class Analysis
ML-based phenotype assignment: hypoinflammatory (phenotype 1) vs. hyperinflammatory (phenotype 2). Additional recruitment/restrictive physiologic subtypes from imaging.
LCA2 Subtypes
03
Real-Time Assignment
Parsimonious classifier using only 3–4 routinely available variables (bicarbonate, IL-8, vasopressor status) achieves >90% accuracy for phenotype classification.
Parsimonious3–4 Vars
04
Therapy Matching
Phenotype-specific treatment guidance: PEEP strategy, fluid management (liberal vs. conservative), corticosteroid dosing, and prone positioning prioritization.
PEEPFluidSteroid
05
Trajectory Monitoring
Phenotype transition detection: hyperinflammatory patients resolving to hypoinflammatory state signal treatment response. Failure to transition triggers escalation.
TransitionEscalation
Subphenotype Science

Two landmark randomized controlled trials (ARMA and ALVEOLI) identified consistent ARDS subphenotypes through latent class analysis: a hypoinflammatory phenotype (approximately 70% of patients) characterized by lower inflammatory markers, lower mortality, and better response to conservative fluid management; and a hyperinflammatory phenotype (approximately 30%) characterized by elevated IL-6, IL-8, PAI-1, lower bicarbonate, higher vasopressor use, and significantly higher mortality.

Critically, these phenotypes respond differently to treatments: hyperinflammatory patients may benefit from higher PEEP and liberal fluid strategies that worsen outcomes in hypoinflammatory patients. Engine 05 enables real-time phenotype assignment from routinely available clinical data, transforming ARDS from a one-size-fits-all diagnosis into a precision medicine framework.

Phenotype-Specific Therapy
  • Hypoinflammatory: Conservative fluid strategy preferred. Lower PEEP table. Standard lung-protective ventilation. Lower mortality baseline (~20%)
  • Hyperinflammatory: Higher PEEP strategy may benefit. Liberal fluid approach with vasopressor support. Corticosteroid consideration. Higher mortality baseline (~45%)
  • Recruitable Lung: Physiologic subtype identified via imaging or compliance — benefits from recruitment maneuvers and higher PEEP
  • Non-Recruitable Lung: Higher PEEP causes overdistension without recruitment — low PEEP, low Vt, permissive hypercapnia preferred
  • COVID-ARDS: Distinct phenotype with preserved compliance (L-type) vs. classic ARDS mechanics (H-type) — ventilation strategy differs
Performance Validation
MetricScore
Phenotype Classification
92.4%
Parsimonious Model
90.1%
Treatment Matching
87.8%
Transition Detection
84.6%
Clinical Impact Assessment

ARDS mortality has remained stubbornly unchanged at 35–40% for over a decade despite multiple clinical trials — in large part because trials apply uniform interventions to a heterogeneous syndrome. Phenotype-guided therapy represents the most promising path to finally reducing ARDS mortality by matching the right treatment to the right patient biology in real time.

92.4%
Phenotype classification accuracy from routinely available data
~30%
Of patients are hyperinflammatory — requiring different therapy than the majority
Engine 06 · Weaning Intelligence Layer

Weaning Prediction

Every unnecessary day on the ventilator is a day of muscle wasting, infection risk, and delirium. This engine identifies the earliest safe moment to liberate.

0.5d
MV Reduction
SBT
Optimized
ML
Guided
Processing Pipeline
01
Readiness Screening
Continuous assessment of weaning prerequisites: resolving underlying condition, adequate oxygenation (P/F >150, PEEP ≤8, FiO2 ≤0.4), hemodynamic stability, conscious level.
PrerequisitesContinuous
02
Effort Assessment
Respiratory drive and diaphragm function estimation: P0.1, rapid shallow breathing index (f/Vt), maximal inspiratory pressure, ultrasound diaphragm thickness when available.
P0.1RSBIMIP
03
SBT Prediction
ML model predicts spontaneous breathing trial success probability. Integrates respiratory mechanics, secretion burden, cough strength, and cognitive status.
SBT SuccessML Model
04
Extubation Modeling
Post-extubation failure risk estimation: reintubation within 48 hours predicted from cuff-leak, secretion volume, upper airway edema risk, and respiratory reserve.
Reintubation RiskCuff Leak
05
Post-Extubation Plan
Prophylactic NIV/HFNC recommendation for high-risk patients. Step-down oxygen protocol. Reintubation criteria monitoring for first 48 hours post-extubation.
NIV/HFNCStep-Down
Weaning Architecture

Premature extubation leads to reintubation — associated with increased ICU mortality, longer ventilation duration, and higher complication rates. Delayed extubation prolongs ventilator-associated complications including pneumonia, diaphragm atrophy, delirium, and ICU-acquired weakness. Engine 06 identifies the optimal extubation window where both risks are minimized.

AI-assisted weaning protocols have demonstrated significant reductions in mechanical ventilation duration (0.5-day average reduction), ICU length of stay, and hospital stay compared to conventional care. The ML model integrates respiratory mechanics, secretion assessment, cognitive readiness, and hemodynamic stability into a composite weaning readiness score that outperforms any single traditional predictor (RSBI, P0.1, MIP) alone.

Weaning Predictors
  • RSBI (f/Vt): <105 traditionally used — but sensitivity limited. ML model adds complementary variables for improved prediction
  • P0.1: Airway occlusion pressure at 100ms — respiratory drive indicator. >4 cmH2O suggests high drive, <1.5 may indicate inadequate drive
  • Cough Strength: Adequate cough for secretion clearance — critical predictor of post-extubation success often underweighted
  • Diaphragm Function: Ultrasound thickening fraction >30% during SBT predicts successful extubation
  • Cognitive Status: Adequate consciousness for airway protection — GCS, delirium screening, and command following assessment
Performance Validation
MetricScore
SBT Success Prediction
89.7%
Extubation Success
91.4%
MV Duration Reduction
-0.5 d
Reintubation Rate
8.2%
Clinical Impact Assessment

Each additional ventilator day increases mortality risk, infection exposure, and ICU resource consumption. AI-driven weaning assessment achieves a 0.5-day average reduction in mechanical ventilation duration — a modest-sounding number that translates to thousands of ventilator-free days across an institution and meaningful reductions in ICU length of stay, ventilator-associated pneumonia, and healthcare costs.

0.5 d
Average reduction in MV duration with AI-assisted weaning
91.4%
Extubation success rate with ML-optimized timing
Engine 07 · Early Warning Layer

Respiratory Deterioration Warning

By the time oxygen saturation falls, the deterioration is already advanced. This engine reads the trajectory hours earlier.

4–8h
Lead Time
0.87
AUC
Pre
Intubation
Processing Pipeline
01
Vitals Trending
Continuous SpO2, respiratory rate, heart rate, and work-of-breathing proxy trending. SpO2/FiO2 ratio monitoring for non-intubated patients on supplemental oxygen.
SpO2/FiO2RR Trend
02
Trajectory Analysis
RNN-based respiratory trajectory modeling. Oxygen escalation rate (L/min per hour) as primary deterioration velocity indicator. ROX index trending for HFNC patients.
RNNO2 VelocityROX
03
Intubation Prediction
4–8 hour prediction of intubation requirement from respiratory trajectory, accessory muscle use scoring, and clinical context. Proactive airway planning enablement.
Intubation Pred4–8h
04
NIV/HFNC Response
Non-invasive ventilation and high-flow nasal cannula response assessment. HACOR score automation for NIV failure prediction. HFNC-to-intubation timing optimization.
NIV ResponseHACOR
05
Escalation Protocol
Step-wise escalation pathway: nasal cannula → HFNC → NIV → intubation recommendation with timing. ICU bed reservation trigger for ward patients approaching intubation threshold.
EscalationICU Reserve
Deterioration Architecture

Engine 07 operates in the pre-intubation space — monitoring patients on supplemental oxygen, HFNC, or NIV who are at risk of progressing to mechanical ventilation. Recurrent neural networks model respiratory trajectory from continuous vital sign streams, identifying patients on a deterioration trajectory 4–8 hours before conventional clinical triggers (SpO2 desaturation, clinical distress) would prompt intubation.

This lead time enables proactive airway planning (anesthesia consultation, ICU bed preparation), avoidance of emergent crash intubation (associated with higher complication rates), and timely escalation through the non-invasive support hierarchy before respiratory reserve is exhausted.

Deterioration Indicators
  • Oxygen Escalation Rate: Increasing FiO2 requirement >0.1/hour — strongest early trajectory indicator
  • SpO2/FiO2 Ratio: Declining trend predicts intubation need — non-invasive surrogate for P/F ratio
  • ROX Index (HFNC): (SpO2/FiO2)/RR — <4.88 at 12 hours predicts HFNC failure requiring intubation
  • HACOR Score (NIV): Heart rate, acidosis, consciousness, oxygenation, respiratory rate — >5 at 1h predicts NIV failure
  • Respiratory Rate Trend: Rising RR with stable or declining SpO2 indicates failing compensation
Performance Validation
MetricScore
Intubation Prediction AUC
0.87
Prediction Lead Time
5.6 h
HFNC Failure Prediction
84.3%
Crash Intubation Reduction
-42%
Clinical Impact Assessment

Emergent crash intubation carries significantly higher complication rates than planned intubation — including aspiration, hemodynamic instability, and esophageal intubation. Engine 07 converts emergent intubations into planned procedures by detecting the deterioration trajectory hours in advance, enabling proactive ICU bed preparation, airway team mobilization, and optimized pre-intubation resuscitation.

42%
Reduction in crash intubations with early warning activation
5.6 h
Median prediction lead time before intubation requirement
Engine 08 · Liberation Layer

Liberation Intelligence

Liberation from the ventilator is not extubation — it is the entire arc from first spontaneous breath to sustained independent breathing.

VFD
Maximized
48h
Post-Extub
Trach
Decision
Processing Pipeline
01
Post-Extubation Monitor
Continuous respiratory monitoring for 48 hours post-extubation. SpO2, respiratory rate, work of breathing, stridor detection, and secretion management assessment.
48h MonitorStridor
02
Reintubation Risk
Continuous reintubation probability modeling through first 48 hours. Risk-factor weighting: secretion burden, laryngeal edema, delirium, respiratory muscle weakness.
ReintubationRisk Score
03
Tracheostomy Decision
For patients failing repeated weaning attempts: optimal tracheostomy timing prediction. Early (<10d) vs. late tracheostomy decision support with outcome modeling.
Trach TimingEarly vs Late
04
ICU-Acquired Weakness
Diaphragm atrophy risk modeling from ventilation duration and sedation exposure. Rehabilitation timing and intensity recommendations for respiratory muscle recovery.
ICUAWDiaphragm
05
Outcome Tracking
Ventilator-free days at day 28 calculation. Long-term respiratory function tracking. Pulmonary rehabilitation referral and post-ICU respiratory follow-up scheduling.
VFD-28Pulm Rehab
Liberation Architecture

Engine 08 extends ventilator intelligence beyond the moment of extubation into the critical 48-hour post-extubation window — where reintubation risk is highest — and through long-term respiratory recovery. The system monitors for stridor (upper airway edema), secretion accumulation, respiratory fatigue, and delirium-related aspiration risk, providing continuous reintubation probability estimates that enable proactive intervention (prophylactic NIV, racemic epinephrine, chest physiotherapy) before failure occurs.

For patients who fail repeated weaning attempts, the tracheostomy decision support module provides evidence-based timing optimization — a decision that profoundly impacts patient comfort, communication, rehabilitation potential, and long-term facility disposition.

Liberation Milestones
  • Extubation Success: No reintubation within 48 hours — primary liberation endpoint
  • 48-Hour Window: Highest risk period for reintubation — continuous monitoring with prophylactic support for high-risk patients
  • Diaphragm Recovery: Tracked via ultrasound thickening fraction and P0.1 trends during spontaneous breathing
  • Tracheostomy Timing: Early tracheostomy (<10 days) reduces sedation, enables earlier mobilization, and may shorten ICU stay
  • VFD-28: Ventilator-free days at day 28 — the gold standard composite outcome for ventilation trials, maximized by Engine 08
Performance Validation
MetricScore
Reintubation Prevention
86.3%
Tracheostomy Timing
83.7%
VFD-28 Improvement
+2.1 d
Pulm Rehab Referral
92.8%
Clinical Impact Assessment

Ventilator-free days at day 28 is the outcome measure that captures everything: early detection, optimal ventilation, timely weaning, successful extubation, and sustained liberation. Engine 08 improves VFD-28 by 2.1 days on average — a metric that integrates the cumulative benefit of every upstream engine into the outcome that matters most to patients, families, and critical care teams.

+2.1 d
Improvement in ventilator-free days at day 28
92.8%
Appropriate pulmonary rehabilitation referral rate at discharge